Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
CV
Cadrenal Therapeutics, Inc. Common Stock
CVKD
Mkt Cap
$3.9M
Volume
161.15K
Next Earnings
November 9th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
CV
CVKD
CV
Cadrenal Therapeutics, Inc. Common Stock
CVKD
News
·
Cadrenal Therapeutics Highlights Research Supporting 12-LOX Inhibition in Reducing Inflammation in Obesity and Type 2 Diabetes
Mkt Cap
$3.5M
Volume
161.15K
Next Earnings
November 9th
Chart
Financials
Earnings
News
About
Insider
Filings
Cadrenal Therapeutics Highlights Research Supporting 12-LOX Inhibition in Reducing Inflammation in Obesity and Type 2 Diabetes
Cadrenal Therapeutics announced research findings demonstrating that its first-in-class 12-LOX inhibitor CAD-1005 can reduce inflammation associated with obesity and Type 2 diabetes. Preclinical studies showed CAD-1005 improved glycemic control, reduced pancreatic β-cell loss, and lowered inflammatory markers. The company believes CAD-1005 could complement existing GLP-1 obesity medications. CAD-1005 is currently in clinical development for Heparin-Induced Thrombocytopenia (HIT), with a Phase 2 trial showing reduced thrombotic events.
GlobeNewswire Inc. · Mar 12, 2026
Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT)
Cadrenal Therapeutics acquired VLX-1005, a novel small-molecule inhibitor targeting heparin-induced thrombocytopenia (HIT), from Veralox Therapeutics. The drug candidate has shown promising Phase 2 results and received Orphan Drug and Fast Track designations from the FDA.
Benzinga · Dec 11, 2025
Kuick Research Releases Landmark Study On US Orphan Drug Rare Disease Market Highlighting Investment And Innovation Opportunities Through 2030
Kuick Research released a comprehensive study on the US Orphan Drug Market, projecting market opportunities exceeding $190 billion by 2030, with over 850 orphan drugs in clinical trials and 500 marketed orphan drugs, highlighting significant investment potential in rare disease therapeutics.
Benzinga · Oct 31, 2025
Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now - GlobeNewswire
The 73rd Emerging Growth Conference is scheduled for July 17-18, 2024, featuring presentations from various companies in the healthcare, technology, and energy sectors.
GlobeNewswire Inc. · Jul 17, 2024
Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session following downbeat results. Compass Minerals Intl posted quarterly adjusted earnings of 5 cents per share, missing market estimates of 26 cents per share. The company’s quarterly sales came in at $341.70 million versus expectations of $357.90 million. Compass Minerals International shares fell 9% to $20.52 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Syra Health Corp. (NASDAQ: SYRA) shares jumped 310% to $4.71 after the company announced a partnership for a federal contract valued at $75 billion. Hitek Global Inc. (NASDAQ: HKIT) surged 305% to $4.6220 after jumping more than 60% on Wednesday. MicroAlgo Inc. (NASDAQ: MLGO) shares climbed 160% to $1.48. CCSC Technology International Holdings Limited (NASDAQ: CCTG) shares gained 90.3% to $4.9299 after falling 20% on Wednesday. U Power Limited (NASDAQ: UCAR) climbed 75% to $0.1153. The company appointed Jean Christophe von Pfetten as an independent director and a member of the Board’s Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee, effective February 1, 2024. WiMi Hologram Cloud Inc. (NASDAQ: WIMI) shares rose 53.3% to $1.2290 after gaining over 26% on Wednesday. Bit Brother Limited (NASDAQ: BETS) shares climbed 51.2% to $2.69 amid strength in Bitcoin. Arm Holdings plc (NASDAQ: ARM) shares climbed 47.3% to $113.41 after the company reported better-than-expected third-quarter financial results and issued FY24 guidance above estimates. Zhongchao Inc. (NASDAQ: ZCMD) rose 41.5% to $0.4250. WeTrade Group, Inc. (NASDAQ: WETG) gained 38.6% to $3.05. Meiwu Technology Company Limited (NASDAQ: WNW) jumped 37% to $1.6205. Healthcare Triangle, Inc. (NASDAQ: HCTI) surged 36% to $3.8250. Oscar Health, Inc. (NYSE: OSCR) shares rose 21.2% to $16.27 after the company reported better-than-expected fourth-quarter financial results. Roma Green Finance Limited (NASDAQ: ROMA) shares gained 20.4% to $0.94 after declining over 5% on Wednesday. Mineralys Therapeutics, Inc. (NASDAQ: MLYS) surged 18.5% to $14.77. Mineralys Therapeutics announced ...
Benzinga · Feb 8, 2024
Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading. 4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150 demonstrating favorable tolerability & clinical activity in wet AMD. 4D Molecular Therapeutics shares jumped 20.1% to $21.01 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Chenghe Acquisition Co. (NASDAQ: CHEA) gained 68.1% to $9.23 in pre-market trading after dipping around 46% on Friday. Tritium DCFC Limited (NASDAQ: DCFC) shares jumped 51.9% to $0.1990 in pre-market trading. Tritium DCFC said the company was the top-awarded fast charger manufacturer for the first round of the State of Tennessee’s National Electric Vehicle Infrastructure (NEVI) Formula Program. YanGuFang International Group Co., Ltd. (NASDAQ: YGF) gained 27.4% to $0.7641 in pre-market trading after falling around 19% on Friday. Magic Empire Global Limited (NASDAQ: MEGL) shares gained 21.6% to $0.9841 in pre-market trading. CalAmp Corp. (NASDAQ: CAMP) ...
Benzinga · Feb 5, 2024
Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarter financial results. Skechers said fourth-quarter revenue increased 4.4% year-over-year to $1.96 billion, which missed the consensus estimate of $2.03 billion, according to Benzinga Pro. The company reported quarterly earnings of 56 cents per share, which beat analyst estimates of 54 cents per share. Skechers shares fell 6.9% to $59.21 on Friday. Here are some other stocks moving in today's mid-day session. Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares jumped 77.6% to $4.28. Intelligent Bio Solutions said it sees preliminary second-quarter revenue of $0.76 million. Minim, Inc. (NASDAQ: MINM) shares rose 34.4% to $6.76 after gaining more than 22% on Thursday. Remark Holdings, Inc. (NASDAQ: MARK) shares climbed 33% to $0.6802. Kopin Corporation (NASDAQ: KOPN) jumped 30% to $2.4050. BioRestorative Therapies, Inc. (NASDAQ: BRTX) rose 26.3% to $2.73. Mountain Crest Acquisition Corp. IV (NASDAQ: MCAF) gained 23% to $14.65. Tyra Biosciences, Inc. (NASDAQ: TYRA) gained 21.8% to $15.84. Tyra Biosciences announced a $200 million private placement financing. Meta Platforms, Inc. (NASDAQ: META) rose 18.9% to $469.34 as the company reported upbeat fourth-quarter financial results and initiated a quarterly dividend of 50 cents per share. CCSC Technology International Holdings Limited (NASDAQ: CCTG) gained 18.2% to $4.6099 after dipping around 82% on Thursday. Roma Green Finance Limited (NASDAQ: ROMA) gained 15.8% to $0.8697 after gaining around 5% on Thursday. Deckers Outdoor Corporation (NYSE: DECK) surged 14% to $879.03 after reporting better-than-expected third-quarter financial results. Trugolf, Inc. (NASDAQ: TRUG) shares jumped 14% to ...
Benzinga · Feb 2, 2024
Why Tellurian Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Shares of Tellurian Inc. (NASDAQ: TELL) shares rose sharply in pre-market trading following a report suggesting the company hired Lazard to explore a possible sale. Tellurian shares jumped 16.3% to $0.6050 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Inspire Veterinary Partners, Inc. (NASDAQ: IVP) gained 99.9% to $0.3817 in pre-market trading after jumping over 22% on Thursday. Jaguar Health, Inc. (NASDAQ: JAGX) gained 29.1% to $0.1485 in pre-market trading after gaining around 12% on Thursday. TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares jumped 27.2% to $2.22 in pre-market trading following a 15% decline on Thursday. RiskOn International, Inc. (NASDAQ: ROI) gained 21.8% to $0.1481 in pre-market trading after gaining over 9% on Thursday. Vision Marine Technologies Inc. (NASDAQ: VMAR) shares climbed 19.7% to $0.9530 in pre-market trading. Cyngn Inc. (NASDAQ: CYN) surged 16.3% to $0.25 in pre-market trading. Cyngn shares jumped over 17% on Thursday after the ...
Benzinga · Jan 26, 2024
Why Netflix Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
Shares of Netflix, Inc. (NASDAQ: NFLX) shares rose sharply in today’s pre-market trading as the company reported better-than-expected sales for its fourth quarter. Netflix reported fourth-quarter revenue of $8.83 billion, which was up 12.5% year-over-year. The total came in ahead of a Street consensus estimate of $8.72 billion. The company reported fourth-quarter earnings per share of $2.11, which missed a Street consensus estimate of $2.21. The company, meanwhile, added 13.12 million net paid subscribers in the fourth quarter. Netflix shares jumped 10.2% to $542.48 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Getaround, Inc. (NYSE: GETR) gained 50.7% to $0.2771 in pre-market trading after the company announced a new debt facility with Mudrick Capital Management for up to $20 million. Evaxion Biotech A/S (NASDAQ: EVAX) gained 43.2% to $7.15 in pre-market trading after a 13G filing showed Merck & Co reported an 11.4% stake in the company as of December 21, 2023. VS MEDIA Holdings Limited (NASDAQ: VSME) shares jumped 31.7% to $0.4318 in ...
Benzinga · Jan 24, 2024
Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the consensus of $1.532 billion. Adjusted EPS of 25 cents topped the street view of 23 cents. KeyCorp shares fell 5.4% to $13.10 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares jumped 92.8% to $0.1824 after falling 5% on Wednesday. Agrify Corporation (NASDAQ: AGFY) shares jumped 90% to $2.2401. Agrify said it entered into first Hydrocarbon Extraction Lab & Vertical Farming unit facility in California. Phunware, Inc. (NASDAQ: PHUN) shares jumped 67.9% to $0.2730. Phunware shares dipped 61% on Wednesday after the company announced pricing of a $7 million registered direct offering price at-the-market under Nasdaq rules. Celularity Inc. (NASDAQ: CELU) shares surged 43.4% to $0.2705 after falling more than 5% on Wednesday. Marpai, Inc. (NASDAQ: MRAI) shares jumped 34.4% to $1.1359 after declining over 8% on Wednesday. Marpai recently named John Powers as President. Akoustis Technologies, Inc. (NASDAQ: AKTS) gained 21.7% to $0.7698. Baijiayun Group Ltd (NASDAQ: RTC) gained 18.8% to $3.73. M.D.C. Holdings, Inc. (NYSE: MDC) rose 18.2% to $62.76 after the company announced it will be acquired by Sekisui House. CURO Group Holdings Corp. (NYSE: CURO) gained 15.7% to $0.8499. Lexeo Therapeutics, Inc. (NASDAQ: LXEO) rose 13% to $19.58. Aurora Technology Acquisition Corp. (NASDAQ: ATAK) gained 13% to $4.79. Acasti Pharma Inc. (NASDAQ: ACST) jumped 12.4% to $2.45. Dada Nexus Limited (NASDAQ: DADA) gained 11.8% to $1.6750. Dada Nexus recently announced that it discovered suspicious practices in an internal audit. Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) surged ...
Benzinga · Jan 18, 2024
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
CV
CVKD
Cadrenal Therapeutics, Inc. Common Stock
Buy
Sell
Market
Limit
Soon
CVKD
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any CVKD yet.
Related Tickers
Earnings